Nathaniel Davies has held various roles in computational biology and bioinformatics at companies such as T-Cypher Bio, Nucleome Therapeutics, and Immunocore. Nathaniel has experience in setting up computational biology teams, initiating drug development pipelines, and working on target discovery databases. Prior to their industry roles, Nathaniel conducted research on immune escape mechanisms of pancreatic cancer as a Postdoctoral Researcher at the University of Birmingham. Nathaniel holds a PhD in Genetics from the University of Leicester, a Master's degree in Computer Science & Artificial Intelligence from Loughborough University, and a Bachelor's degree in Computer Software Engineering from Derby College.
March 1, 2024 - present
March, 2023
April, 2021
Senior Director, Computational Biology at Verve Therapeutics
Senior Director Computational Biology and AI at BiomEdit
Senior Director, Computational Biology - NGS Bioinformatics at Ultima Genomics
Senior Director, Computational Biology at Foundation Medicine
Senior Director, Computational Biology Assay Research & Development at Freenome